Authors


Jonathan Alicea

Latest:

Psoriasis Associated with Increased Risk for Retinal Diseases

More research is needed to understand the pathogenesis underlying this association.


Thy Huynh, MD

Latest:

Dermatologic differences in a diverse population

Understanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.


Jenna Le

Latest:

Seasonal Efficacy and Tolerability of Tazarotene in Warmer vs Colder Months

Researchers have explored whether the adverse effects of tazarotene are exacerbated during the colder winter months and whether there is variation in treatment efficacy and tolerability between cold vs warm seasons.


Naiem Issa, MD, PhD, FAAD

Latest:

Insights From the 16th 5CC World Congress

Naiem Issa, MD, PhD, shared highlights from his sessions on the 1726 nm laser for acne, atopic dermatitis disease modification, advances in hidradenitis suppurativa, and microneedling techniques for vitiligo.


Helen T Shin, MD

Latest:

Examining Molecular Differences in PDE4 Inhibitors in Pediatric Patients with Plaque Psoriasis

Panelists discuss how the two approved PDE4 inhibitors for pediatric plaque psoriasis differ in their systemic treatments, highlighting key differences in efficacy, safety profiles, and patient considerations for optimal use.


Stephen Tyring, MD, PhD, MBA

Latest:

Antimicrobial Resistance: Challenges and Potential Solutions

Stephen Tyring, MD, PhD, MBA, covers the burden of antimicrobial resistance and the need for alternative treatments.


Justine Cohen, DO

Latest:

Frontline Forum Part 4: Improving Basal Cell Carcinoma Management

In the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.



Marni Jameson Carey

Latest:

A Health Care Price Transparency Revolution is at Hand

Payers must make public the individual amounts their health plans pay providers across all types of services and locations, including hospitals, doctors’ offices, imaging centers, outpatient surgery centers and urgent care clinics.


Mitchell Hanson

Latest:

Advancing Sexual Health Histories in Dermatology: A Modernized Comprehensive Approach for Diverse Populations

In recent years, there has been a noticeable rise in diagnoses of sexually transmitted infections, often which present with skin findings.


Sponsored by Novartis Pharmaceuticals Corporation

Latest:

Chronic Spontaneous Urticaria Management and the Role of Patient Communication

Dr. Jonathan Rodrigues highlights challenges in management of patients with chronic spontaneous urticaria and why shared decision-making is critical.


Lauren Biscaldi

Latest:

ICYMI: US FDA Recently Approves Stelara Biosimilar Ustekinumab-aekn for Psoriasis, Psoriatic Arthritis

Last week, the US Food and Drug Administration approved biosimilar ustekinumab-aekn (Selarsdi; Alvotech and Teva) for psoriasis and PsA.


Brandon Beal, MD

Latest:

Getting Started With Practice Tech: Pearls From Brandon Beal, MD

Brandon Beal, MD shared his experience, which technology solutions work best, and resources available to dermatology practices.



E. James Song, MD, FAAD

Latest:

Comparison of Systemic Therapies for Plaque Psoriasis

An expert on plaque psoriasis provides an overview of systemic therapy options and provides clinical insights on patient monitoring practices and best courses of action when treatment response isn’t sustained.


Will Kirby, DO, FAOCD

Latest:

A New Role for Will Kirby, DO, FAOCD

How does a dermatologist go from the clinic to the television screen? Editorial Board member Will Kirby, DO, FAOCD, shares his thoughts about reality television and his appearance The Traitors.


Jeffrey Bendix

Latest:

Study Finds Disparities in Access to Patient Portals Despite a Rise in Use

The study found that white patients were offered access to patient portals more frequently than Black or Hispanic patients.


Nic McMahon

Latest:

Improve Patient Outcomes With Better Language Access

Medical practices can choose from a wide array of tools to enable communication with patients from diverse backgrounds.


Nicole A. Negbenebor, MD

Latest:

Neoadjuvant and Adjuvant Vismodegib for Complex Basal Cell Carcinomas

To improve overall outcomes for patients with large basal cell carcinomas, it has been beneficial to employ the use of vismodegib as a neoadjuvant and/or adjuvant treatment.


Anjeza Fero, PharmD, RPh

Latest:

The Role of Pharmacists in Providing Patient Counseling On Topical Niacinamide For Acne and More

Niacinamide is a versatile skincare ingredient that effectively targets acne, age-related issues, hyperpigmentation, and atopic dermatitis, writes Anjeza Fero, PharmD, RPh.


John Barbieri, MD, MBA, FAAD

Latest:

Benzoyl Peroxide and Benzene: Latest findings from John Barbieri, MD, MBA, FAAD

Researchers behind the latest benzene studies found no increased cancer risk with use of products containing benzoyl peroxide.


Luke Maxfield, DO

Latest:

Opening Doors of Communication: Social Media Trends and Challenges

Luke Maxfield, DO, discusses the importance of understanding social media trends and engaging patients in dialogues.


Darrell Rigel, MD

Latest:

Sunscreen Innovations: Addressing Diverse Photoprotection Needs and Future Directions in Preventive Dermatology

Dr Darrel Rigel provides insights into cutting-edge photoprotection strategies, emphasizing the specific considerations for skin of color patients and the critical role of sunscreen in preventive dermatology.


Grace Halsey

Latest:

Omicron COVID-19 variant: What we know and what we don’t

The Omicron variant of COVID-19 is spreading quickly, jumping continents with infected travelers. Here’s the latest on what global health officials know about it.



Andrew Baker, MBA, MPAS, PA-C

Latest:

More Clinicians are Needed in the Fight Against Skin Cancer

Andrew Baker, MBA, MPAS, PA-C, discusses his role in skin cancer detection and advice for PAs interested in skin surgeries and Mohs closures.


Emily Ruiz, MD, MPH, FAAD

Latest:

Frontline Forum Part 4: Improving Basal Cell Carcinoma Management

In the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.


Adelle Infante

Latest:

Nkem Ugonabo, MD, MPH, and Adelle Infante: Mentorship of Young Women and Girls in STEM, Dermatology

Allergan Aesthetics recently announced the fifth-year of its partnership with Girls Inc. Nkem Ugonabo, MD, MPH, and Adelle Infante recently spoke with Dermatology Times to discuss the importance of STEM and dermatology mentorship.


Ashley Chan

Latest:

Higher Treatment, Health Care Costs Associated With Advanced Melanomas

Greater treatment costs are associated with more advanced stages of melanoma, particularly due to increasing prices of treatments.


Brett King, MD, PhD

Latest:

Optimizing Patient Outcomes with JAK Inhibitors

Brett King, M.D, Ph.D and Alexandra Golant, M.D summarize their thoughts on optimizing treatment outcomes for patients suffering from atopic dermatitis with the JAK inhibitor class.

© 2024 MJH Life Sciences

All rights reserved.